DEVELOP ANTI-MALARIA DRUG: These four persons played important roles in developing a new anti-malaria drug at Parke, Davis & Company's Ann Arbor Research Laboratories. They are (left to right) Dr. Paul E. Thompson, laboratory director in parasitology; Dr. E. F. Elslager, laboratory director in organic chemistry; Donald F. Worth, associate research chemist, and Miss Bronislawa Olszewski, assistant research biologist. All are co-authors of a paper which announces the new experimental drug.
Rights Held By
Donated by the Ann Arbor News. © The Ann Arbor News.